Sarcoma: all 1,691 studies
Page 15 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Aerosol L9-NC and Temozolomide in Ewing's SarcomaCompletedNCT00492141Phase 1/2
- Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.CompletedNCT00484341Phase 2
- Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryCompletedNCT00450736Phase 1
- Sirolimus in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00450320Phase 1
- Anti-Retrovirals for Kaposi's SarcomaCompletedNCT00444379Phase 4
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsCompletedNCT00433407Not applicable
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Pemetrexed in Patients With Soft Tissue SarcomaCompletedNCT00427466Phase 2
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNCT00427414Phase 1
- Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue SarcomaCompletedNCT00423618Phase 3
- Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
- Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaStatus unknownNCT00410462Phase 2
- BAY-43-9006 in Advanced, Metastatic Soft Tissue SarcomasCompletedNCT00406601Phase 2
- A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasCompletedNCT00401388Phase 2
- Development of Serologic Assays for Human Herpes Virus-8CompletedNCT00395278
- An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized TrialCompletedNCT00384735
- Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian CancerCompletedNCT00383279Not applicable
- HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTCompletedNCT00380770Phase 4
- Combination Chemotherapy in Treating Young Patients With Nonmetastatic RhabdomyosarcomaStatus unknownNCT00379457Phase 3
- Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug IndinavirCompletedNCT00362310Phase 2
- Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GISTCompletedNCT00359333Phase 2
- Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerStatus unknownNCT00349024Not applicable
- PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue SarcomaCompletedNCT00346125Not applicable
- Collection of Alveolar Soft Part Sarcoma and Blood Specimens for ResearchCompletedNCT00340353
- Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in SicilyCompletedNCT00339937
- Prognostic Value of a Positive RT-PCR Test in Patients With Ewing SarcomaCompletedNCT00339898
- Risk Factors for Non-HIV-Related Kaposi s SarcomaCompletedNCT00339326
- PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue SarcomaCompletedNCT00335751Not applicable
- Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWithdrawnNCT00334984Not applicable
- Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's SarcomaWithdrawnNCT00334867Phase 3
- Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaStatus unknownNCT00334854Phase 3
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Nicotine Skin Patch in Treating Patients With Kaposi's SarcomaCompletedNCT00295984Phase 2
- Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic CancerCompletedNCT00295945
- TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma PatientsCompletedNCT00289809Phase 1/2
- Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTerminatedNCT00288444Phase 1
- Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)CompletedNCT00288431Phase 1
- Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerCompletedNCT00287885Phase 1
- BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaTerminatedNCT00287495Phase 1
- Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideCompletedNCT00283621Not applicable
- Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive ChemotherapyCompletedNCT00283582Phase 3
- Irinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaCompletedNCT00276692Phase 2
- Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)CompletedNCT00276302Phase 1
- Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue SarcomaCompletedNCT00276055Phase 1
- Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's SarcomaTerminatedNCT00265902Not applicable
- Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaCompletedNCT00258687Phase 1
- Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.CompletedNCT00258401Not applicable
- Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for ApoptosisCompletedNCT00243685Phase 2/3
- Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaCompletedNCT00227669Phase 2
- Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
- A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care TreatmentNo longer availableNCT00210665
- Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)CompletedNCT00204646Phase 2
- Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)CompletedNCT00204620Phase 2
- Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)Status unknownNCT00204568Phase 2
- Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast CancerCompletedNCT00194766Phase 2
- Study of Low Dose CT in Sarcoma PatientsCompletedNCT00188422Phase 1
- IMRT Lower Limb Soft Tissue SarcomaCompletedNCT00188175Phase 2
- Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
- Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' GirdleStatus unknownNCT00181025Phase 2
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid TumorsStatus unknownNCT00179816Phase 1/2
- Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and SarcomasCompletedNCT00165139Phase 2
- The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine SarcomasStatus unknownNCT00162721Phase 3
- Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue SarcomaCompletedNCT00142571Phase 3
- Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
- A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal SarcomaCompletedNCT00131898Phase 3
- a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4CompletedNCT00130858Phase 2
- Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue SarcomaTerminatedNCT00123786Phase 2
- PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to ImatinibCompletedNCT00117299Phase 2
- Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)CompletedNCT00116935Phase 3
- Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT00112645Phase 1
- Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaCompletedNCT00104949Phase 2
- A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue SarcomaCompletedNCT00102609Phase 1
- Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or NeuroblastomaStatus unknownNCT00101309Phase 1
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNCT00101127Phase 2
- Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryCompletedNCT00098579Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
- MRI Sarcoma Non Invasive ThermometryCompletedNCT00093509Phase 1/2
- Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)CompletedNCT00093080Phase 2
- Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or PelvisCompletedNCT00091351Phase 3
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerTerminatedNCT00089245Phase 1
- A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue SarcomasCompletedNCT00087997Phase 2
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal TumorCompletedNCT00087074Phase 2
- Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaCompletedNCT00085475Phase 2
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesStatus unknownNCT00084695Phase 2
- Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma ProtuberansCompletedNCT00084630Phase 2
- Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue SarcomaSuspendedNCT00079950Phase 2
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaActive, not recruitingNCT00077285Phase 2
- Valproic Acid in Treating Patients With Kaposi's SarcomaCompletedNCT00075777Not applicable
- Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or LymphomaStatus unknownNCT00072488Not applicable
- Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorCompletedNCT00069940Phase 1
- Perifosine in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00064324Phase 2